Subscription Status · Mar 24 – Mar 27, 2026 · ₹372–392
The Sai Parenteral's IPO subscription has recorded adequate investor demand with an overall subscription of 1.08× as of Mar 27, 2026, indicating that investors applied for 1.08 times the number of shares on offer. All investor categories (institutional, HNI, and retail) have participated actively, making this one of the closely watched IPO openings.
Last updated: Mar 27, 2026, 5:59 PM IST
| Category | Shares Offered | Shares Bid For | Times Subscribed |
|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
2,085,659 | 3,610,266 |
1.73×
|
|
NII
Non-Institutional Investors
|
1,564,243 | 3,831,502 |
2.45×
|
|
bNII
Bids above ₹10L
|
1,042,829 | 3,707,318 |
3.56×
|
|
sNII
Bids below ₹10L
|
521,414 | 124,184 |
0.24×
|
|
Retail
Retail Individual Investors
|
3,649,901 | 439,204 |
0.12×
|
|
Total
|
7,299,803 | 7,880,972 |
1.08×
|
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times |
|---|---|---|---|
| QIB | 2,085,659 | - | 0.00× |
| NII | 1,564,243 | 238,336 | 0.15× |
| bNII | 1,042,829 | 224,390 | 0.22× |
| sNII | 521,414 | 13,946 | 0.03× |
| Retail | 3,649,901 | 97,128 | 0.03× |
| Total | 7,299,803 | 335,464 | 0.05× |
| Category | Offered | Bid For | Times |
|---|---|---|---|
| QIB | 2,085,659 | 1,260,574 | 0.60× |
| NII | 1,564,243 | 1,636,622 | 1.05× |
| bNII | 1,042,829 | 1,615,570 | 1.55× |
| sNII | 521,414 | 21,025 | 0.04× |
| Retail | 3,649,901 | 185,630 | 0.05× |
| Total | 7,299,803 | 3,082,826 | 0.42× |
| Category | Offered | Bid For | Times |
|---|---|---|---|
| QIB | 2,085,659 | 3,610,266 | 1.73× |
| NII | 1,564,243 | 3,831,502 | 2.45× |
| bNII | 1,042,829 | 3,707,318 | 3.56× |
| sNII | 521,414 | 124,184 | 0.24× |
| Retail | 3,649,901 | 439,204 | 0.12× |
| Total | 7,299,803 | 7,880,972 | 1.08× |
As of March 27, 2026, the Sai Parenteral's IPO has been subscribed 1.08 times overall. The IPO is fully subscribed.
The Sai Parenteral's IPO subscription window was open from March 24, 2026 to March 27, 2026. Investors could apply through their demat account or ASBA facility.
The Sai Parenteral's IPO has a price band of ₹372 to ₹392 per share, with a lot size of 38 shares. Minimum retail investment: ₹14,136 (lower band) or ₹14,896 (upper band).
The QIB category has been subscribed 1.73 times. QIBs were offered 2,085,659 shares.
Retail investors subscribed 0.12 times. Retail was offered 3,649,901 shares. Below 1× indicates moderate retail interest.
Overall NII: 2.45×. bNII (>₹10L): 3.56×, sNII (<₹10L): 0.24×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on March 30, 2026. Check via the registrar's website, Bigshare Services Private Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Sai Parenteral's IPO is expected to list on April 02, 2026. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 1.08× means investors have bid for 1.08 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 0.12×, the estimated allotment probability for retail investors is High. Applicants likely to get full allotment. If final subscription stays below 1×, all applicants are likely to get full allotment.
You can apply for Sai Parenteral's IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Mar 24 to Mar 27, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Sai Parenteral's IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.
New to reading subscription numbers? Read our guide on IPO subscription explained.
Subscription Opens Done
Mar 24, 2026Subscription Closes Done
Mar 27, 2026Basis of Allotment Done
Mar 30, 2026Listing on NSE,BSE Done
Apr 02, 2026Applicants likely to get full allotment. Based on retail subscription of 0.12×.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.